Citius Oncology Inc (CTOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,563 | N/A | 1,386 | 1,228 | 612 |
| Income taxes - deferred | 288 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -785 | N/A | N/A | N/A | N/A |
| Other Working Capital | 5,401 | N/A | 386 | 78 | -21 |
| Other Operating Activity | 4,659 | 0 | -2,155 | -1,576 | -760 |
| Operating Cash Flow | $0 | $N/A | $-383 | $-269 | $-169 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | N/A | N/A | -660 | N/A | N/A |
| Investing Cash Flow | $N/A | $N/A | $-660 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 780 | 350 | N/A |
| Financing Cash Flow | $N/A | $N/A | $780 | $350 | $N/A |
| Beginning Cash Position | N/A | N/A | 289 | 289 | 289 |
| End Cash Position | N/A | N/A | 27 | 370 | 120 |
| Net Cash Flow | $0 | $N/A | $-263 | $81 | $-169 |
| Free Cash Flow | |||||
| Operating Cash Flow | 0 | N/A | -383 | -269 | -169 |
| Free Cash Flow | 0 | 0 | -383 | -269 | -169 |